Published in Women's Health Weekly, February 28th, 2002
Rudi Bao and colleagues at the Philadelphia, Pennsylvania cancer center have developed a ovarian tumor-targeted gene therapy composed of a plasmid containing the ovarian specific promoter (pOSP1) and expressing the enzyme herpes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.